JGC
JNCE

J. Goldman & Co’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

J. Goldman & Co’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-24,120
Closed -$539K – 344
2018
Q1 		$539K Sell
24,120
-25,880
-52% -$578K 0.02% 181
2017
Q4 		$638K Buy
+50,000
New +$638K 0.03% 156